Saint James Hospital is Malta’s largest private hospital group, with hospitals in Sliema and Żejtun, an Eye Clinic in Birkirkara, an Out-Patient Clinic in Burmarrad and an Aesthetic Clinic in Mriehel as well as an Eye and Aesthetics Centre in Budapest, Hungary. Its CEO, Jean Claude Muscat, joined the family business at the age of 19 and has spent more than three decades helping to build it.
We talk about where medicine is heading amid rapid advances and breakthroughs, revisit the rough times in Libya during Gaddafi and post revolution, and explore how private healthcare in Malta coexists with the state-funded healthcare system.
Saint James is the largest private hospital group in Malta and is often described as the most innovative. Apart from Mater Dei, the state hospital, who do you consider your competition?
Our main ‘competitor’ probably remains Mater Dei, simply because it is a free service. The government invests taxpayers’ money, and openly communicates how much it invests. We, on the other hand, serve patients who either pay for their care or are insured, at a time when healthcare is becoming more expensive every day. So our market is what it is.
Many of the specialists employed at Mater Dei also work with us and have their own sessions, clinics and patient pathways there. The advantages of private care are well known: faster access, the ability to choose your surgeon or specialist, and more comfort, with a private room and a hotel-like environment.

Do you see that competition as healthy, or would you prefer a different arrangement?
I would much prefer to find a way for Saint James and other accredited private hospitals (that meet the required quality and standards), to work together with the public system, rather than be in competition with it. As things stand, I believe we (government as well as private) are losing efficiency and effectiveness on both sides. We invest in the same things and compete where there is no real need to.
There is also a difference in mindset. Whenever we invest, it is our own money, money we put at risk from our own income or through third party financing. The government invests public money. So rather than using those funds that may tend to compete with the private sector, I would encourage it to say: let us look at the resources we have as a country and pool them, to come up with solutions that benefit the patient, the doctor and Malta as a whole. That would make far more sense than both sides doing more of the same.
Saint James has invested heavily in robotic surgery, and the group recently announced around €36 million in new investment. Which steps would you single out as the most important?
A few years ago we decided that rather than continuing to grow organically, it was time to make a real difference. Private hospitals in Malta were seen as a secondary option to the state hospital. The thinking was: if it is serious, go to Mater Dei; if it is not, you can go to Saint James. We wanted to change that.

The first thing we did was build two new emergency departments, staffed by fully qualified emergency specialists. That means that when you come to Saint James, even with a serious medical condition, you can be treated here. People assume we would simply transfer them to Mater Dei. Today, that rarely happens.
On a small island, there is still a perception that a bad outcome in the public hospital is accepted as part of medicine, while in a private hospital it is judged far more harshly. But we are a multi-disciplinary, acute care hospital. We care for people who are seriously ill, and we are gradually noticing a shift in the public’s mindset: that being treated at Saint James is a viable option.
Beyond emergency care, which services have made the biggest difference?
Our idea was to raise our game. We wanted to become a one-stop shop, an acute hospital where even very complex cases can be treated privately. That is how we stay relevant and grow. So alongside emergency care, we invested in robotics, which is the most advanced form of surgery available today. That alone was a €3.5 million investment.
In October 2026 we also opened our cardiac care unit through which we are now able to perform cardiac interventions, allowing us to continue raising our game, backed by an investment of €2.5 million. This is another first for Saint James, and one which emphasises my earlier point.
That is a lot of growth in a short time. How do you make sure quality keeps pace with it?

It is not only about investing in equipment. Our philosophy has always been to build strong foundations first. Once we decided to grow, diversify and become a one-stop shop, we started with the basics: employing the right people and making sure that all our divisions, clinics and branches are accredited. Saint James holds internationally recognised ISO certification, demonstrating that our management systems, operational processes and quality standards meet established international benchmarks. This certification reflects our commitment to excellence, consistency and continuous improvement, ensuring that the high standards synonymous with Saint James are maintained across all our facilities and services.
Why does that matter? Because it gives patients peace of mind. There are processes and systems in place, so whoever is involved in your care delivers the same type and quality of care that people associate with the Saint James name. That is what guarantees safety and accountability.
Once that was in place, we could invest more in our infrastructure, be it equipment or property development. We are building a large emergency department at our Żejtun hospital as well as a new Eye Hospital on the same site.

In our Sliema hospital we have built a new endoscopy department, and we are opening two new major orthopaedic theatres this month.
How are these investments financed? Is it all the company’s own capital, or do you also bring in outside investors?
Thus far, it has all been our own investment. We are a family business. Most of our financing comes from our own capital, our own cash flow and bank financing.
The Company has doubled in size in the last 5 years. However, if we want to keep growing at this pace – and our plans are ambitious – I believe we will need to consider other forms of financing in the future.
As you broaden your services, are you also looking at foreign patients? Many countries are actively competing for medical tourism. Is that a focus for you, or do you mainly serve Maltese patients?
I believe there is a lot of misconception around medical tourism. Between 2006 and 2008 we conducted quite an extensive study on attracting health travelers to Malta. We looked at the USA, visited Canada and travelled around Europe. We found that the biggest market was America, but Americans barely knew that Malta existed.
Malta is far better known and better connected today.
I agree that it is different now, but through our extensive research in 2006, what we found was that people travel for medical treatment for two main reasons. Either they are seeking very cheap treatment – which is where I believe Turkey has been very successful – or money is no issue and therefore they are seeking centers of excellence. If it is a condition related to the spine, they go to one country; if it is the brain, they go to another. So, it is either the very best, or treatment at a much lower price than at home.
In other words, the best value for money.
Not necessarily – I simply do not think price should be the deciding factor in a medical decision, but rather the deciding factors should be quality of care, standard of the facility and its equipment, and reputation of both the clinical team and the hospital or clinic. Still, it is surprising how many people do travel on price. What I realised was that Malta hits neither of those markets for two reasons. We are not the most super-specialised in the world, and we are not the cheapest.
Malta does have something to offer, though: recovery on a sunny island, and a complete package around the treatment.
People do not really reason like that when it comes to their healthcare options. We need to attract a specific niche clientele, and the rest is a bonus. With that, we have concluded that we need to specialise. We are looking at bariatrics (weight loss surgery), for example, with a Maltese, Italian and a French team who have come together, and we want to be the best at what we do in that specialisation. We are also very strong and very advanced in cataract surgery and laser eye surgery.

Ultimately, it is very difficult to be a one-stop shop for everyone. You cannot simply market Malta as a medical travel destination. It requires a much more complex and supportive set-up, including elements which are extraneous to the care received alone. You need experienced surgeons. You need to get the pricing right. You need good support from the companies that supply medical equipment and consumables, because if everyone in the chain aims for the maximum mark-up, it will not work, and you will never compete on price. You need reasonable airline fees, and accommodation for rehabilitation. Malta is not a cheap destination. Our level of healthcare is very good, and our hospitals are excellent. But all these elements backed by committed government support need to come together for Malta to be considered seriously as a strong medical tourism destination.
What do you think explains Turkey’s success? Is it scale, lower wages, cheaper access to materials?
The medical tourism strategy in Turkey is strongly supported by the government. If your flight arrives late and you need an overnight stay, you get a free hotel. Supporting logistical services are subsidised. They have access to a huge market, so the cost of healthcare is lower. Turkey is not in the EU, and they buy consumables at prices far below what we pay.
Let me give you an example. Our cost for bariatric surgery, just the consumables alone – leaving aside the surgeon’s fee, staff cost, the theatres, overnight stays, pharmaceuticals and so on – is around €1,500 per operation – this is for the consumables used for that specific single surgery alone. In Turkey, the price of the entire bariatric procedure is around €3,000, including a two-night stay, the surgeon’s fee, the anaesthetist’s fee, the hospital fee and the nursing care, transportation, etc. It is impossible to compete with that, on price.
In Europe, many items are single-use only: everything is disposed of after use. We can only work with specific registered suppliers, and products must be CE-marked. Our doctors also expect to work with the highest-quality brands. As I understand it, suppliers outside the EU are not bound by the same requirements, their products cost far less, and some items can be reused, which we are not allowed to do. It is a different ball game.
What would need to change in the EU for European providers to become more competitive? Which areas, in your view, are overregulated?
We have become very regulated, which on the one hand is good, because standards improve. However, you also have to be careful not to overregulate. We have GDPR, now the EU Pay Transparency Directive, ESG reporting, and there is always something new being introduced. We can only use CE-marked products, which makes sense, but there is limited control over prices. If an importer wants to bring in a particular medicine, the registration process is so complicated and so expensive that the end price is high as well. In that environment, competing on price is a non-starter.
Where do you feel that burden most in your day-to-day work?
In the administration. I was just passing by our quality department on my way up, and I happened to look at the manager’s whiteboard: an ISO inspection here, a public health inspection there, an Aero Medical Centre Audit tomorrow, NSO reports to submit, collection and presentation of data and outcomes, it doesn’t stop. We have whole teams working only on the administrative side, separately of the clinical side.
With every new piece of legislation, you need to consult your legal team, and people to manage the requirements. Every claim can become a court case or a fine, and that is part of your costs. Over and above there are insurance costs and IT costs, to name a few.
About a year ago we had a cyber-attack, a direct and very complex one, and it was extremely difficult to deal with. Even the EU’s IT specialists departments became involved. That is how it should be, but everything comes at a cost. When you compare a highly regulated environment with a less regulated one, the cost difference is massive.
If you could change one thing in the regulatory approach, what would it be?
We need regulation, but it also has to be practical and at times specific to the industry. Rather than adding more and more requirements, hospitals must be accredited (same as with the hotel industry), identify which ones comply with clearly defined standards, and grade them accordingly. There is no grading of hospitals in Malta today. We need to grade hospitals based on published and audited outcomes – both private hospitals as well as government hospitals. Patients generally go wherever their doctor sends them and trust that all will go well. I believe patients deserve clearer information than that.
So let us grade hospitals. If you have a certain grade, you can perform certain types of surgery; to give a simplistic example – with an A grade, you can perform certain type of procedures, with a B grade the Hospital can perform a different category of procedures etc.
Across Europe, many countries face shortages of doctors and long waiting times for diagnostics and specialist care. In some countries, people sometimes wait up to two years to see a psychologist or start certain therapies. Is this something Malta struggles with as well?
It affects Malta too, and it is one of the Island’s biggest challenges. Waiting lists are always a challenge; we hear more about them when an election is coming up. However, I believe that with better management, better systems and processes, and a stronger central administrative authority, the situation can improve immensely. That includes, as I said at the beginning, working with accredited private hospitals and allowing the system to specialise, rather than one government hospital having to cope with everything.

Why do you think that has not happened so far?
I often ask myself why Mater Dei needs to do everything. Private entrepreneurs can build other hospitals and clinics at their own expense, and I believe that we could perform elective surgeries, trauma and specific procedures at a price equal to or at a lower cost than it costs the government. Instead, more work is added to the same hospital, and the pressure keeps growing. When things become stretched, some work is passed to the private sector, but that tends to be a short-term solution. What I would like to see is a planned, long-term strategy.
To be fair, more than ever before there seems to be a tangible change in strategy, with a number of longer-term initiatives being discussed between the health authority and the private sector. I am a firm believer that with such a strategy, these challenges can be addressed together as one and resolved at a cost that is reasonable and that the country can afford.
There is still much to be done in this area, and I firmly believe that closer collaboration between the public and private healthcare sectors is key to achieving meaningful progress. By establishing a clear, transparent and properly costed framework, with specialised facilities delivering dedicated services under a unified, well-regulated and sustainably financed healthcare system, we can create a more efficient and effective model of care. Malta’s relatively small size presents a unique opportunity to make such a model both practical and successful.
We constantly hear about millions being spent on one project and hundreds of millions on another, and now we are talking in billions. I would like to see it presented in context, as a percentage of the country’s current or projected revenue and expenditure.
At Saint James Hospital, every major investment is carefully scrutinised by our Board: why is it needed, what return will it generate and how many procedures will it deliver? I would welcome a similar approach to public healthcare investment, with greater visibility of the financial planning, expected outcomes and long-term sustainability of such initiatives.
Do you struggle to find skilled specialists? Do you need to recruit many from outside the EU?
There are some rare specialisations that are hard to find across most of Europe, and we face the same difficulty. Although, medical services in Malta are well covered by very competent and professional doctors who can provide a full service.
The real challenge for us is recruiting into the private sector. The way the system works, doctors are usually employed full-time by the government first and then work part-time in private practice. It is something I would like to see evolve over time, although I recognise it is a difficult situation to change. As a result, it is actually easier for us to employ a foreign doctor than a Maltese specialist.
Saint James has also expanded abroad – to Hungary and, earlier, to Libya, which is not the most predictable market. Why those countries?
Libya was a very different place when we started that project, in 2003, when Gaddafi was still in power. We were asking ourselves where to go next: if we wanted significant growth, should we invest in Malta, or look at bigger markets? We decided to look at bigger markets.
At the time, the Libyan ambassador’s wife had given birth at Saint James, and my father, who is an obstetrician, delivered the baby. The ambassador said to him: “Doctor, why don’t you consider building a healthcare facility in Libya, which is lacking?” It was a challenge, but we set up a clinic in Libya in 2005 and it was doing very well.
What changed?
Then came the uprising in 2011, and a second conflict in 2014. In 2015 our general manager was kidnapped, marking an exceptionally difficult and distressing period for everyone involved.
How was it resolved?
It ended well. The kidnappers asked for a ransom, but we did not pay one. We were well supported by the Maltese and Libyan security services, and they managed to resolve the matter safely. It is not a secret, and it shows that healthcare is not always as straightforward as people think. When you go into unstable markets, one needs to be aware of the associated risk.
And why Hungary?
For a company of our size, even today, we look towards investing in developing markets. Saint James is a family business; we cannot go to another developed market and build a hundred-million hospital. So we go into developing markets, start relatively small, learn the market and grow. That is what we had done in Libya, where we were building a hospital along the same capacity of Saint James in Sliema before things fell apart after the uprising. We lost a lot of money there.
Hungary followed the same logic. I went there with a Hungarian contact, saw the place and liked it. My initial idea was to invest in aesthetic services, but I soon realised there was an aesthetic clinic or salon on every corner, so that would not work. Then we analysed the ophthalmology market: a population of around two million people and only three ophthalmic clinics in Budapest. We saw room to enter, and we invested in ophthalmology. We developed it over the years into a very successful facility becoming market leader in Cataract & Refractive Lens Exchange Surgery, and last year we invested a further €7 million in a brand-new clinic. Today it offers ophthalmology, laser surgery, cataract and retinal work, and in the same building we have a facility with another two operating theatres and 16 in-patient beds for plastic and aesthetic surgery. We have now been successfully operational in Hungary for seventeen years.
How do you estimate what a market will need? Do you look at disease prevalence, ageing, other statistics?
We take a broad view, continuously monitor what is happening in global healthcare, and the approach we take depends on the market and appetite. In Libya, we understood there was a big gap even in primary healthcare, so in a sense it was easier to build from the ground up. We started with a good GP service, then added the supporting services, and positioned ourselves as a family clinic that could cater for all your needs.
In Hungary it was different. There we decided to specialise rather than offer general medical services. Ophthalmology was something we had already done in Malta and in Libya, and a field we understood well. We studied the market: how many clinics there were, the size of the population, and where ophthalmology was heading. It was clear it had the opportunity to grow significantly.
How has the field changed in that time?
When we first started doing cataract surgery, the eye had to be physically opened with a wide surgical incision. Today it is a ten-minute procedure with no stitches – I have had it done myself. That expands the market considerably, and people are having cataract surgery at an earlier stage. Many now also choose to have their natural lens replaced purely for refractive reasons, so they can see clearly without glasses. If you are over 45, you can have a procedure similar to cataract surgery, where your natural lens is removed and a premium lens is implanted. This is more commonly known as RLE. Alternatively, there is laser surgery to remove the need for glasses altogether.
To be fair, I am 55 and I joined Saint James at 19. I have done hundreds of projections, and I do not think I have ever got one exactly right. Projections and budgeting gives you an idea and help identify where the opportunity is. Sometimes you exceed your projections, sometimes you fall short. That is where business skill comes in: knowing how to manage the situation in order to survive and grow.
To answer your question more directly; the markets we entered have changed over time. Recently, we took the difficult decision to close our operations in Libya. Following the unrest, it became too unstable for us to continue to operate there, it just was no longer a viable operation considering our investments in both recruitment and infrastructure, aside from safety.
The Hungary market has also changed. Specialisations have continued to evolve and the private market has grown; several other ophthalmology clinics have opened over the years which has allowed for the market to become increasingly competitive.
With the amount of time we all spend on screens, demand for eye care seems fairly predictable.
People are living longer, and with age the natural lens in the eye becomes slightly opaque. Above a certain age, whether we like it or not, the eye muscle also gets tired and compensates less, so people start needing reading glasses. Twenty or thirty years ago, that was fine, and it still is. But today, many people prefer not to depend on reading glasses, especially when playing sports, or for reading a menu at a restaurant, or simply to read messages on their phone.
Our lifestyles are different today. We are out and socialising much more than before, we are constantly on our phones reading small text, and we are very conscious of our physical appearance. All of these factors mean that demand for eye procedures are likely to remain strong and continue to grow.
Looking further ahead, what will the hospital of the future look like?
If we look ten or twenty years ahead, I can see a major shift towards predictive healthcare. People will be diagnosed before they even walk into a hospital. Many find this hard to imagine, but with smartwatches and similar devices, we will be monitoring patients twenty-four hours a day.
With AI supported algorithms, we will be able to predict whether you are likely to suffer a cardiac episode. Instead of feeling chest pain, calling an ambulance and requiring an emergency intervention, we will be able to anticipate that you are at risk of a heart attack through the monitoring of your vital signs, call you in and treat you before it happens. Hospital treatment itself will cost less as a result, while more outpatient care will happen before admission.
And inside the hospital?
That raises big questions. Will we have enough nurses and enough doctors? Will there be systems that analyse a patient’s anatomy so that surgery and diagnostic work is carried out by robots? I believe that will happen. Even today, in robotic surgery the surgeon is not standing over the patient but sitting in the corner of the theatre at a console, operating with joysticks. I think it is fair to say that we expect inpatient hospital treatment to also change drastically.
Will robots or other non-human support services be accepted in patient care? Today, certainly not. If I gave you a robot to care for you, you would probably reject it. Albeit in ten years’ time or sooner, it may well be the norm. We need to be ready to be part of this transformation, not just accept it but take part in it, promote it and encourage it. That is the direction we are taking.
Many people already wear smartwatches. Do you see those being connected directly to a hospital, so that patients are registered there and receive an alert when something looks wrong?
The future is already on our doorstep through these advanced technologies. Actually, we have now created a system to connect the readings generated by the devices to a call centre at SJH. Preparations for the launch of this initiative are underway as we speak.
So. this is much closer than it might sound.
Yes, but monitoring alone is not yet predictive. That is the next step. At the moment, people look at their watches. In the future we will probably also have non-wearable devices that monitor everything at home without you having to wear anything. The question is how far it will be developed, and how readily accepted will it be. For now, we need to connect these devices and their readings to a contact centre and to a hospital that has the set-up to react and call you in.
Beyond that, I think we will see AI-driven predictive medicine: the ability to know that you are going to suffer an episode before it happens. We will have robotic companions at homes able to support the patient and deliver approved medical services. The possibilities are limitless now. In the long term, this will save lives and it will save costs. It will change the game.
How close are we to that?
Very close. We are getting very close.
Are hospitals flexible enough to adopt such systems quickly once they are ready?
Hospitals do tend to be heavy by the very nature of their structure. I often say a hospital is one of the most complex organisations to run. In a hospital ecosystem you need to consider the patient, the doctor, the relatives, the equipment / technology investment, the different staffing levels, the laboratory, the various specialised departments etc. – which all need to come together to deliver a seamless, safe and pleasant experience to the client. By the nature of what encompasses a hospital, we are quite heavy, because we are highly structured. Flexibility becomes somewhat more challenging..
However, if you can see what is coming next, you can prepare the hospital, the team and the set-up to be part of that progress. Otherwise, especially in the private sector, you risk falling behind. The challenge is that medical equipment and new technology are very expensive, and it takes years for prices to come down. That is where we need to be smart: obtaining the right technology, at the right price, at the right time. Getting those aligned is a big part of my job. We definitely need to be open to it, and more than open – part of it. You cannot wait for it to happen and then jump on board.
Would you describe yourself as a technology enthusiast?
Not really. I am a realist. I can see what is happening, and it is my job to understand, pre-empt and embrace its impact (positive or negative).
So, you see technology as a necessity rather than a passion?
It is obvious that this is the way the world is going. You reacted the same way when I mentioned the watches: you told me it is already happening. But that is only a small part, and now we can take it to another level. Technology does not bother me, and I am comfortable with it, but I wouldn’t consider myself an enthusiast.
People seem to fall into two camps: those who look forward to a world of gadgets and AI, and those who feel nostalgic for human interaction and the way things used to be run.
I would leave nostalgia aside. I have learned that it is a form of looking backwards, and that is a luxury we cannot afford. People like Elon Musk change how the world works years before anyone else sees it. What we see today is the result of planning and thinking that started who knows how many years ago. We can never compare ourselves to him or to SpaceX, because they are genuinely changing the world. We are not; but we want to be ready, to understand where the world is going, and to make sure our hospitals are prepared to embrace that change and that technology.
What is your own background?
I was practically born into healthcare. I joined Saint James at nineteen, and my father, disappointed that I had stopped studying, made sure I started at the very bottom. Saint James was a much smaller organisation back then, and over the years I worked my way up, building relationships with doctors, listening to their needs and gradually gaining a deeper understanding of the business. Many years later, I completed a Master’s in Business Administration, partly to prove to myself that I could succeed academically too. My journey up the ladder took place one step at a time, to where I am today.
So you are a businessman rather than a doctor, someone who sees the hospital from a helicopter view.
Yes, but as the organisation grew and became more complex, I realised that running a healthcare business is about much more than the bottom line, and to be successful, I had to appreciate the complexities of the clinical side very well. Ultimately, it is about managing people and bringing together the administrative and clinical sides of the organisation. Both must work closely together, as decisions made on one side inevitably affect the other. Involving people in the process also helps build trust, cooperation and support for change.
Being a businessman does not mean I can make decisions in isolation. We operate within a highly regulated environment, and I remain accountable to our Board of Directors. A significant part of my role is bringing people together, aligning them towards common goals and gaining their support to achieve long-term results. Throughout all of this, patient safety and quality of care must remain our priorities, alongside ensuring the financial sustainability of the organisation, not just today, but for the years ahead.






